Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • California guideCalifornia Bids and Bidding Guide
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›California
  4. ›Healthcare and Medical Services
  5. ›Rapid DNA Instrument

Awarded contract·County of Orange·California

Rapid DNA Instrument

Won by Life Technologies Corporation$300kSingle Award
Contract source

Awarded vendors

  • Life Technologies Corporation

Description

The contract is for the purchase of a Rapid DNA Instrument, as indicated by the "title" field. The contract was awarded to Life Technologies Corporation, and the County of Orange is the contracting agency. The contract is classified as a Sole Source procurement. The scope of work is not explicitly stated, but it can be inferred that the contract is for the purchase of equipment for laboratory use. Key points about the contract include: • The contract is for a Rapid DNA Instrument • The contract was awarded to Life Technologies Corporation • The contract is classified as a Sole Source procurement • The contract duration is 3 years • The contract value is not explicitly stated, but it can be estimated based on industry standards for similar equipment.

Attached files

The award documents live at the source — open the contract source above to download them.

Key dates

Starts
10/4/2024
Ends
10/3/2027
Duration
3 years

Last updated

Details

Award type
Single Award
Procurement
Sole Source
Industry
Healthcare and Medical Services
NAICS
541380
Solicitation №
CT-060-25010382

Contract value

$300,000

The contract value is not explicitly stated, but based on industry standards for similar equipment, it can be estimated to be around $100,000 to $500,000. This estimate takes into account the cost of similar DNA analysis equipment and the duration of the contract. However, without more information, it is difficult to provide a more accurate estimate.

AI estimate from the award documents

Similar open opportunities

Matched by Bid Banana AI™

LA County Sheriff·California

Top match · 67%

RFSQ - DNA Laboratory Services

Rolling / TBD closeOpened 11/9/2021

U.S. Department Of Defense·Maryland

66% match

Notice of Intent DNA Synthesizer

Closes 11/2/2026Opened 10/15/2026

U.S. Bureau of Justice Assistance·United States of America

64% match

BJA FY26 DNA Capacity Enhancement for Backlog Reduction (CEBR)?Competitive Grants Program

Closes 11/3/2026Opened 9/23/2026

U.S. National Institutes of Health·United States of America

63% match

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Closes 3/1/2027Opened 1/8/2026

Georgia Fulton County Purchasing Department·Georgia

63% match

26ITB1702547C-JH DNA Services

Closes 11/10/2026Opened 10/13/2026

U.S. Department Of Health And Human Services·Maryland

63% match

RNA sequencing and whole genome sequencing services

Closes 11/6/2026Opened 10/28/2026

U.S. National Institutes of Health·United States of America

62% match

ancient DNA for Modern Genomics (aDMG) Research Projects (U01 Clinical Trials Not Allowed)

Closes 1/31/2028Opened 6/2/2026

Iowa State University·Iowa

62% match

Blood Spot and Dried Urine Testing

Closes 11/6/2026Opened 10/23/2026

Tarrant County·Texas

62% match

Purchase of Genetic Analysis Instrument and Maintenance

Closes 11/5/2026Opened 10/16/2026

U.S. Department Of Health And Human Services·Maryland

62% match

NOI - DNA Sequencing of Bone Marrow Failure Syndro

Closes 11/2/2026Opened 10/22/2026

U.S. National Institutes of Health·United States of America

61% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. Bureau of Justice Assistance·United States of America

61% match

BJA FY 2026 Postconviction Testing of DNA Evidence

Closes 12/8/2026Opened 10/28/2026

U.S. Department Of The Interior·United States of America

61% match

Q--MOJAVE TORTOISE BIOINFORMATICS

Closes 10/31/2026Opened 10/21/2026

U.S. Department Of Defense·Mississippi

60% match

Handheld X-Ray Fluorescence for ERDC GSL

Closes 12/3/2026Opened 11/26/2025

U.S. Department Of Energy·Ohio

60% match

TECHNOLOGY LICENSING OPPORTUNITY: Multi-Channel Atomic Magnetometer (MCAM)

Closes 12/12/2026Opened 7/17/2026

U.S. Department Of Defense·United States of America

60% match

Non-Optical Methods for High Speed Protein Control

Closes 12/31/2026Opened 7/21/2026

New York City Police Department·New York

60% match

05627Y0268-Rigaku XRD Instrument

Closes 11/4/2026Opened 10/21/2026

U.S. National Institutes of Health·United States of America

60% match

RNomics Technology Enhancement Centers

Closes 1/31/2027Opened 8/5/2026

University of Massachusetts·Massachusetts

60% match

UMass Amherst University Health Services - Laboratory and/or Clinical Molecular Analyzer

Closes 11/6/2026Opened 10/5/2026

U.S. National Institutes of Health·United States of America

59% match

Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)

Closes 9/7/2027Opened 11/18/2024

U.S. National Institutes of Health·United States of America

59% match

Transformative Technologies for Experimental and Computational RNome Characterization and Functional Analysis

Closes 2/14/2027Opened 8/5/2026

U.S. National Institutes of Health·United States of America

59% match

Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)

Closes 11/5/2029Opened 2/11/2026

U.S. National Institutes of Health·United States of America

59% match

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)

Closes 9/10/2027Opened 12/13/2024

U.S. National Institutes of Health·United States of America

58% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

58% match

Limited Competition: Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed)

Closes 1/26/2029Opened 8/27/2025